← Evidence map

ReviewTherapeutic advances in drug safety2020

Structured benefit-risk evaluation for medicinal products: review of quantitative benefit-risk assessment findings in the literature.

Marie-Laure Kürzinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33343857